Mergers and Acquisitions Takeover Bids

  • Allergan CEO: Fighting Ackman 'all consuming'

    David Pyott, Allergan chairman & CEO, discusses the company's historic quarter, Bill Ackman's failed attempt to take over the company and the decision to subdivide the management team.

  • Here's where sovereign wealth funds are moving their money to

    Sunac plans to buy a 49.3 percent stake in troubled Chinese developer Kaisa, which recently missed bond coupon payments, Caixin magazine reported.

  • A bid for Blackberry?

    Anil Doradla, William Blair & Company, shares his views on the smartphone maker's future after reports rise Samsung could be making a bid for the company.

  • Verizon CEO on AOL: Not in acquisition talks

    Verizon CEO Lowell McAdam states AOL and other media companies are potential partners, but they are not in significant acquisition talks with AOL. CNBC's David Faber reports.

  • Faber Report: Verizon-AOL logic

    CNBC's David Faber reports Verizon has approached AOL about a potential joint venture or takeover.

  • Club Mediterrannee is expected to back an offer from a consortium led by Chinese billionaire Guo Guangchang, after a rival declined to raise his offer.

  • 3 hedge fund predictions for 2015

    CNBC's Kate Kelly reveals what investors can expect from hedge funds and activists in 2015.

  • Investing on speculation

    Leigh Drogen, Estimize CEO, discusses his "Mergerize" platform, and CNBC contributor Herb Greenberg, discuss if it is ever a good idea to invest in a company based on takeover speculation.

  • Valeant's bid for Allergan

    Michael Pearson, Valeant Pharmaceuticals CEO, shares his thoughts on allegations Allergan released false and misleading information.

  • Airline Virgin Australia has coughed up a whopping one Australian dollar to buy the 40 percent of Tiger Australia it didn't already own.

  • Actavis plans new Allergan approach: Report

    According to Reuters, Actavis plans to make a new approach for a takeover of Allergan. CNBC's Dominic Chu reports Allergan would be open to sale at a price over $200 a share.

  • Consolidation buzz in beer biz

    After Heineken rebuffed SABMiller's takeover proposal, CNBC's Morgan Brennan takes a look at global beer consumption.

  • Scripps CEO: Focused on quality

    CNBC's David Faber speaks to Ken Lowe, Scripps Networks Interactive chairman & CEO, about consolidation and if Scripps would entertain a takeover bid.

  • Dollar General goes hostile

    CNBC's David Faber reports Dollar General has gone hostile in its bid for Family Dollar. Faber says Family Dollar is proceeding with its plans to be bought by Dollar Tree in a deal for less than what Dollar General is offering.

  • General Mills' $820 million deal

    CNBC's David Faber reports General Mills is buying Annie's for about $820 million. Cramer breaks down the dynamics of the acquisition.

  • Dollar General to raise Family Dollar bid: Sources

    According to sources, Dollar General is raising its bid for Family Dollar to $80 per share, with CNBC's Andrew Ross Sorkin.

  • Dollar General bid worth $9.7 million

    Dollar General is making a bid to buy Family Dollar for about $9.7 billion. Joe Feldman, Telsey Advisory Group, discusses the likelihood of whether Dollar Tree could come back with a counter bid.

  • CNBC's Andrew Ross Sorkin reports Dollar General is making a bid to buy Family Dollar for about $9.7 billion. The combined company would have 20,000 stores.

  • Ackman speaks to CNBC's Wapner on SEC probe reports

    The Dow Jones is reporting the SEC is in early stages of investigating Valeant and Pershing Square's pursuit of Allergan. CNBC's Scott Wapner has the details.

  • DJ: SEC looking into pursuit of Allergan

    The Dow Jones is reporting the SEC is investigating Valeant and Pershing Square's pursuit of Allergan. CNBC's Scott Wapner has the details.